Laurence Klotz focuses on Prostate cancer, Internal medicine, Surgery, Prostate and Cancer. Her Prostate cancer research is multidisciplinary, incorporating perspectives in Biopsy, Radiology and Gynecology. Her research integrates issues of Endocrinology and Oncology in her study of Internal medicine.
Laurence Klotz combines subjects such as Nephrectomy, Kidney disease and Urology with her study of Surgery. Her Prostate research is multidisciplinary, relying on both Hormonal therapy and General surgery. In the subject of general Cancer, her work in PCA3 is often linked to Erg, Fusion gene and TMPRSS2, thereby combining diverse domains of study.
The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Oncology, Cancer and Surgery. Her Prostate cancer research integrates issues from Prostate, Disease and Urology. Her Prostate research focuses on Biopsy and how it relates to Prostate biopsy.
Her work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Gynecology. Her studies in Oncology integrate themes in fields like Stage, Androgen, Bicalutamide and PCA3. Surgery connects with themes related to Cohort in her study.
Laurence Klotz mostly deals with Prostate cancer, Internal medicine, Oncology, Cancer and Radiology. The various areas that Laurence Klotz examines in her Prostate cancer study include Magnetic resonance imaging, Biopsy, Prostate and Disease. Her work in Biopsy addresses issues such as Prostate-specific antigen, which are connected to fields such as Risk assessment and Cohort study.
Within one scientific family, she focuses on topics pertaining to Urology under Prostate, and may sometimes address concerns connected to Prospective cohort study and International Prostate Symptom Score. Laurence Klotz has included themes like Apalutamide, Adverse effect, Enzalutamide, Androgen and Hazard ratio in her Oncology study. Her Cancer study combines topics in areas such as Nephrology and Retrospective cohort study.
Laurence Klotz focuses on Prostate cancer, Internal medicine, Cancer, Biopsy and Oncology. Her work deals with themes such as Magnetic resonance imaging, Radiology and Disease, which intersect with Prostate cancer. Her Internal medicine study incorporates themes from Action plan and Distress.
Her biological study spans a wide range of topics, including Randomized controlled trial and Retrospective cohort study. Her Biopsy research incorporates elements of T-stage, Tumour stage, Repeat biopsy, Prostate biopsy and Receiver operating characteristic. Her Oncology study combines topics from a wide range of disciplines, such as Androgen, Enzalutamide and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley.
JAMA (2011)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco.
The New England Journal of Medicine (2018)
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Laurence Klotz;Liying Zhang;Adam Lam;Robert Nam.
Journal of Clinical Oncology (2010)
Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
Laurence Klotz;Laurence Klotz;Danny Vesprini;Danny Vesprini;Perakaa Sethukavalan;Perakaa Sethukavalan;Vibhuti Jethava;Vibhuti Jethava.
Journal of Clinical Oncology (2015)
A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
Hendrik Van Poppel;Luigi Da Pozzo;Walter Albrecht;Vsevolod Matveev.
European Urology (2007)
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.
Robert K. Nam;Robert K. Nam;Refik Saskin;Yuna Lee;Ying Liu.
The Journal of Urology (2010)
Active Surveillance for Prostate Cancer: A Systematic Review of the Literature
Marc A. Dall’Era;Peter C. Albertsen;Christopher Bangma;Peter R. Carroll.
European Urology (2012)
Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.
Caroline M. Moore;Caroline M. Moore;Nicola L. Robertson;Nasr Arsanious;Thomas Middleton.
European Urology (2013)
Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
J. M Crook;C. J O'Callaghan;G Duncan;D. P Dearnaley.
The New England Journal of Medicine (2012)
Loss of Cyclin-dependent Kinase Inhibitor p27Kip1 Is a Novel Prognostic Factor in Localized Human Prostate Adenocarcinoma
Tsihlias J;Kapusta Lr;DeBoer G;Morava-Protzner I.
Cancer Research (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Princess Margaret Cancer Centre
University of Toronto
University Health Network
University of California, San Francisco
University of British Columbia
University of Montreal
University College London
University of Toronto
Vanderbilt University Medical Center
New York University
MIT
Jinan University
Lund University
OPKO Health (United States)
University of Helsinki
National University of Singapore
University of Utah
Johns Hopkins University
Chinese Academy of Sciences
University of Massachusetts Medical School
Universität Hamburg
Karolinska Institute
Mayo Clinic
Novartis (Switzerland)
Peter MacCallum Cancer Centre
The University of Texas Health Science Center at San Antonio